Othman Al‐Sawaf

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo et al. · New England Journal of Medicine · 2019 · 816 citations

Lung adenocarcinoma promotion by air pollutants

William Hill, Emilia L. Lim, Clare E. Weeden et al. · Nature · 2023 · 663 citations · Full text

Asthma, Lung Deposition, Environmental Lung Diseases +8

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Othman Al‐Sawaf, Can Zhang, Maneesh Tandon et al. · The Lancet Oncology · 2020 · 319 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +14

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Christopher Abbosh, Alexander M. Frankell, Thomas Harrison et al. · Nature · 2023 · 304 citations · Full text

Engineering, Oncologic Imaging, Cancer Detection +8

The evolution of lung cancer and impact of subclonal selection in TRACERx

Alexander M. Frankell, Michelle Dietzen, Maise Al Bakir et al. · Nature · 2023 · 278 citations · Full text